{"cluster": 63, "subcluster": 7, "abstract_summ": " SARS-CoV-2 virus has resulted in a devastating pandemic of COVID-19 . Re-positioning cheap, freely available and safe drugs is a priority . The paper proposes evidence for the potential use of diethylcarbamazine (DEC) in the treatment of the virus . DEC has inhibitory effects on arachidonic acid metabolism to prostaglandins and demonstrated anti-inflammatory actions in animal models of lung inflammation ."}